Women's Health & Pregnancy Clinical Trials

Statistical methods in women's health & pregnancy trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All women's health & pregnancy trials

675 results

• Comparative Effectiveness Study of Bubble CPAP Devices in the NICU: Complete Statistical AnalysisIndependent statistical analysis of Comparative Effectiveness Study of Bubble CPAP Devices in the NICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02392806).Phase NAResults postedn = 43NCT02392806
• Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 12NCT00636077
• Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 214NCT04957212
• Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 39NCT02802176
• Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery: Complete Statistical AnalysisIndependent statistical analysis of Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in…Phase 3Results postedn = 19NCT04588246
• Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02163434).Phase 2Results postedn = 31NCT02163434
• Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE): Complete Statistical AnalysisIndependent statistical analysis of Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 132NCT04519294
• Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 50NCT01705691
• Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03129945).Phase NAResults postedn = 36NCT03129945
• Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement (IUPC) Measurement in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement (IUPC) Measurement in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 20NCT01282710
• CONFIRMIndependent statistical analysis of Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.: primary endpoint…Phase 3Results postedn = 736NCT00099437
• Conservative Treatment of Postprostatectomy Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Conservative Treatment of Postprostatectomy Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00212264).Phase NAResults postedn = 208NCT00212264
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer:…Phase 3Results postedn = 416NCT00320710
• Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01165775).Phase NAResults postedn = 17NCT01165775
• Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 224NCT01303419
• Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 24NCT01936519
• CoQ10Independent statistical analysis of Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 236NCT00096356
• CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: Complete Statistical AnalysisIndependent statistical analysis of CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 222NCT03998163
• Cranberry Effect on Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of Cranberry Effect on Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02996981).Phase NAResults postedn = 167NCT02996981
• Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy: Complete Statistical AnalysisIndependent statistical analysis of Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01388777).Phase 2Results postedn = 1NCT01388777
• Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 8NCT00514215
• Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 18NCT02827877
• Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 35NCT01042938
• CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 43NCT03628716
• Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 63NCT00971737
• D Mannose in Recurrent Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of D Mannose in Recurrent Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01808755).Phase 3Results postedn = 60NCT01808755
• Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 30NCT01720173
• DBSIndependent statistical analysis of DBS for Home Monitoring in Children With Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931397).Phase NAResults postedn = 30NCT01931397
• Decision-aid on Breast Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Decision-aid on Breast Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03097653).Phase NAResults postedn = 1,001NCT03097653
• DEFEAT-AKIIndependent statistical analysis of Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04633889).Phase 2Results postedn = 320NCT04633889
• Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358760).Phase 3Results postedn = 450NCT01358760
• Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates: Complete Statistical AnalysisIndependent statistical analysis of Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986947).Phase 2Results postedn = 20NCT00986947
• Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG: Complete Statistical AnalysisIndependent statistical analysis of Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 200NCT02068820
• Development of Vitamin D as a Therapy for Breast Cancer – Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Development of Vitamin D as a Therapy for Breast Cancer - Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 63NCT00656019
• Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2/3Results postedn = 34NCT02225860
• Digital Intervention To Improve Diet Quality: Complete Statistical AnalysisIndependent statistical analysis of Digital Intervention To Improve Diet Quality: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04098016).Phase NAResults postedn = 54NCT04098016
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 2NCT00354601
• Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01382706).Phase 2Results postedn = 15NCT01382706
• Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 188NCT00486902
• Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 46NCT02207972
• DolphinIndependent statistical analysis of A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB): primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 26NCT04641975
• Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 10NCT02542410
• Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval,…Phase NAResults postedn = 38NCT00615901
• Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976741).Phase 1Results postedn = 168NCT01976741
• Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1Results postedn = 27NCT01761240
• Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 127NCT02030067
• Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 946NCT00535288
• Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01210560).Phase 2Results postedn = 25NCT01210560
• Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 47NCT04351750
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 153NCT00667576

← All therapeutic areas